160 related articles for article (PubMed ID: 38783016)
1. Synthesis and new DNA targeting activity of 6- and 7-tert-butylfascaplysins.
Dyshlovoy SA; Mansour WY; Ramm NA; Hauschild J; Zhidkov ME; Kriegs M; Zielinski A; Hoffer K; Busenbender T; Glumakova KA; Spirin PV; Prassolov VS; Tilki D; Graefen M; Bokemeyer C; von Amsberg G
Sci Rep; 2024 May; 14(1):11788. PubMed ID: 38783016
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in the Synthesis of the Marine-Derived Alkaloid Fascaplysin and Its Metabolites Homofascaplysins A-C.
Mittapalli RR; Kumari H
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611869
[TBL] [Abstract][Full Text] [Related]
3. Study of Structure-Activity Relationships of the Marine Alkaloid Fascaplysin and Its Derivatives as Potent Anticancer Agents.
Zhidkov ME; Kaune M; Kantemirov AV; Smirnova PA; Spirin PV; Sidorova MA; Stadnik SA; Shyrokova EY; Kaluzhny DN; Tryapkin OA; Busenbender T; Hauschild J; Rohlfing T; Prassolov VS; Bokemeyer C; Graefen M; von Amsberg G; Dyshlovoy SA
Mar Drugs; 2022 Mar; 20(3):. PubMed ID: 35323484
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy.
Massey AJ
Cancer Lett; 2016 Dec; 383(1):41-52. PubMed ID: 27693461
[TBL] [Abstract][Full Text] [Related]
5. A New Mild Method for Synthesis of Marine Alkaloid Fascaplysin and Its Therapeutically Promising Derivatives.
Tryapkin OA; Kantemirov AV; Dyshlovoy SA; Prassolov VS; Spirin PV; von Amsberg G; Sidorova MA; Zhidkov ME
Mar Drugs; 2023 Jul; 21(8):. PubMed ID: 37623705
[TBL] [Abstract][Full Text] [Related]
6. Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.
Ando K; Nakamura Y; Nagase H; Nakagawara A; Koshinaga T; Wada S; Makishima M
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362335
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the ATR-CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2.
Koppenhafer SL; Goss KL; Terry WW; Gordon DJ
Mol Cancer Res; 2020 Jan; 18(1):91-104. PubMed ID: 31649026
[TBL] [Abstract][Full Text] [Related]
8. Multiple DNA damage-dependent and DNA damage-independent stress responses define the outcome of ATR/Chk1 targeting in medulloblastoma cells.
Krüger K; Geist K; Stuhldreier F; Schumacher L; Blümel L; Remke M; Wesselborg S; Stork B; Klöcker N; Bormann S; Roos WP; Honnen S; Fritz G
Cancer Lett; 2018 Aug; 430():34-46. PubMed ID: 29753759
[TBL] [Abstract][Full Text] [Related]
9. Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.
Doerr F; George J; Schmitt A; Beleggia F; Rehkämper T; Hermann S; Walter V; Weber JP; Thomas RK; Wittersheim M; Büttner R; Persigehl T; Reinhardt HC
Sci Rep; 2017 Nov; 7(1):15511. PubMed ID: 29138515
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors.
Jackson CB; Noorbakhsh SI; Sundaram RK; Kalathil AN; Ganesa S; Jia L; Breslin H; Burgenske DM; Gilad O; Sarkaria JN; Bindra RS
Cancer Res; 2019 Sep; 79(17):4331-4338. PubMed ID: 31273061
[TBL] [Abstract][Full Text] [Related]
11. Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening.
Guzi TJ; Paruch K; Dwyer MP; Labroli M; Shanahan F; Davis N; Taricani L; Wiswell D; Seghezzi W; Penaflor E; Bhagwat B; Wang W; Gu D; Hsieh Y; Lee S; Liu M; Parry D
Mol Cancer Ther; 2011 Apr; 10(4):591-602. PubMed ID: 21321066
[TBL] [Abstract][Full Text] [Related]
12. PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality-An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness.
Gralewska P; Gajek A; Marczak A; Mikuła M; Ostrowski J; Śliwińska A; Rogalska A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352723
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effects of fascaplysin against small cell lung cancer cell lines.
Hamilton G
Mar Drugs; 2014 Mar; 12(3):1377-89. PubMed ID: 24608973
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of ATR and ATM potentiates the activity of trabectedin and lurbinectedin by perturbing the DNA damage response and homologous recombination repair.
Lima M; Bouzid H; Soares DG; Selle F; Morel C; Galmarini CM; Henriques JA; Larsen AK; Escargueil AE
Oncotarget; 2016 May; 7(18):25885-901. PubMed ID: 27029031
[TBL] [Abstract][Full Text] [Related]
15. Dual Inhibition of GLUT1 and the ATR/CHK1 Kinase Axis Displays Synergistic Cytotoxicity in
Erber J; Steiner JD; Isensee J; Lobbes LA; Toschka A; Beleggia F; Schmitt A; Kaiser RWJ; Siedek F; Persigehl T; Hucho T; Reinhardt HC
Cancer Res; 2019 Oct; 79(19):4855-4868. PubMed ID: 31405847
[TBL] [Abstract][Full Text] [Related]
16. Comparative Evaluation of the Antibacterial and Antitumor Activities of 9-Phenylfascaplysin and Its Analogs.
Zhidkov ME; Sidorova MA; Smirnova PA; Tryapkin OA; Kachanov AV; Kantemirov AV; Dezhenkova LG; Grammatikova NE; Isakova EB; Shchekotikhin AE; Pak MA; Styshova ON; Klimovich AA; Popov AM
Mar Drugs; 2024 Jan; 22(2):. PubMed ID: 38393024
[TBL] [Abstract][Full Text] [Related]
17. Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
Eich M; Roos WP; Nikolova T; Kaina B
Mol Cancer Ther; 2013 Nov; 12(11):2529-40. PubMed ID: 23960094
[TBL] [Abstract][Full Text] [Related]
18. Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines.
Rath B; Hochmair M; Plangger A; Hamilton G
Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30322180
[TBL] [Abstract][Full Text] [Related]
19. Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.
Karanika S; Karantanos T; Li L; Wang J; Park S; Yang G; Zuo X; Song JH; Maity SN; Manyam GC; Broom B; Aparicio AM; Gallick GE; Troncoso P; Corn PG; Navone N; Zhang W; Li S; Thompson TC
Cell Rep; 2017 Feb; 18(8):1970-1981. PubMed ID: 28228262
[TBL] [Abstract][Full Text] [Related]
20. Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis.
Yuan JM; Wei K; Zhang GH; Chen NY; Wei XW; Pan CX; Mo DL; Su GF
Eur J Med Chem; 2019 May; 169():144-158. PubMed ID: 30875505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
